기사 (11,195건)

- Co-developed a mid-to-large sized hydrogen fuel cell forklift with Hyundai Motor Company and Hyundai Construction Equipment - Planning its first trial run next year in Korea, with an aim to commercialization by 2023 - Accelerating the popularization of hydrogen fuel cell cars by devising new related business models SEOUL, South Korea, Sept. 30, 2020 /PRNewswire/ -- Hyundai Mobis (KRX 012330) announced on the 29th that it had succeeded in jointly developing a prototype of a hydrogen fuel cell forklift with Hyundai Motor Company and Hyundai Construction Equipment and would embark on a demonstration project for evaluating the performance of the prototype. The hydrogen fuel cell forklift developed is a mid-to-large sized one that can lift up to five tons of cargo and can be operated continuously for five hours when its hydrogen fuel cell is fully charged. Although small-sized hydrogen fuel cell forklifts designed to carry small items indoors have previously been unveiled, this is actually the first time that a mid-to-large sized hydrogen fuel cell forklift has been developed. The mid-to-large sized hydrogen fuel cell forklift has been fitted with a hydro fuel cell system mass-produced by Hyundai Motor Group, the first of its kind in the world. In the process of doing so, Hyundai Mobis managed to independently develop a fuel cell power pack optimized for hydrogen fuel cell forklifts. The power pack of a hydrogen fuel cell forklift serves as a generator that generates electricity for the hydrogen fuel cell forklift by itself, and it is a system that has integrated components including a fuel cell stack, a high voltage battery, a hydrogen tank and a cooling device. Since the hydrogen fuel cell system used for automobiles could not be applied to its hydrogen fuel cell forklift, Hyundai Mobis developed a customized system for it. Following the development of the hydrogen fuel cell forklift, Hyundai Mobis and other affiliates are also jointly developing a hydrogen fuel cell excavator and plan to develop and introduce a prototype this year. Like the hydrogen fuel cell forklift, Hyundai Mobis also aims to commercialize the hydrogen fuel cell excavator that is currently in development by 2023 after going through processes such as demonstration and pilot projects. About Hyundai Mobis Hyundai Mobis established a mass production system for Hyundai Motor Company's hydrogen fuel cell system and has since been endeavoring to expand its business presence in the hydrogen fuel cell field. Hyundai Mobis currently has the ability to produce hydrogen fuel cells for 23,000 cars per year and plans to expand its production capacity to 40,000 cars per year by 2022. Media Contact Jihyun Han (jihyun.han@mobis.co.kr) Choon Kee Hwang (ckhwang@mobis.co.kr)   Related Links :https://www.mobis.co.kr/

종합 | PR Newswire | 2020-09-30 21:00

사진= 기상청 오늘의(30일) 날씨는 기상청에 따르면 전국이 구름많겠으나, 강원영동북부는 흐리고 비가 오는 곳이 있겠다. 한편, 강원산지와 전국 내륙을 중심으로 짙은 안개가 끼는 곳이 있겠으니, 귀성길 교통안전에 각별히 유의하기 바란다. 오늘(30일) 낮(12시)부터 중부지방(강원영동 제외)에 돌풍과 함께 천둥.번개를 동반한 비가 시작되어 서울.경기도와 충청북부는 오후(18시)에 그치겠고, 일부 강원영서남부는 저녁(21시)까지 이어지는 곳이 있겠다. 한편, 충남서해안과 전라서해안에는 오후 한때(12시~15시) 비가 오는 곳이 있겠다. 특히, 경기동부와 강원영서에는 오늘 오후(12~18시)에 우박이 떨어지는 곳이 있겠다. 한편, 강원영동중북부는 동풍의 영향으로 오늘 아침(06시)부터 내일(10월 1일) 오전(12시) 사이에 비가 오는 곳이 있겠고, 충남서해안과 전라서해안에는 오늘 오전(09시~12시)에 산발적으로 빗방울이 떨어지는 곳이 있겠다. 예상 강수량은 (30일 12시~10월 1일 12시) 강원영동중북부: 5~40mm,  (30일 12시~21시) 서울.경기도, 강원영서, 충남, 충북북부, 전라서해안: 5~20mm이다. 오늘(30일)과 내일(10월 1일) 전국이 구름많겠으나, 중부지방은 오늘 오후(12시)부터 내일 아침(06시)까지 흐리겠니다. 모레(2일) 중부지방은 흐리고, 남부지방은 가끔 구름많겠다. 모레(2일) 오전(12시) 경기북부와 강원영서북부부터 비가 시작되어 오후에는 서울과 경기남부, 강원영서중남부, 충청북부에도 비가 오겠다. 강원영동은 오늘(30일)과 내일(10월 1일) 동풍이 불면서 낮 기온이 20도 내외로 낮겠고, 내륙에는 낮과 밤의 기온차가 10도 이상 크겠다. 오늘(30일) 낮 최고기온은 20~27도가 되겠다. 내일(10월 1일) 아침 최저기온은 11~18도, 낮 최고기온은 20~25도가 되겠다. 모레(2일) 아침 최저기온은 12~18도, 낮 최고기온은 21~26도가 되겠다. 오늘(30일)과 내일(10월 1일) 비가 오는 지역에서는 가시거리가 짧아지고, 도로가 미끄러운 곳이 있겠다. 남해안은 내일(10월 1일)부터 천문조에 의해 바닷물의 높이가 높은 기간이니, 만조 시 해안가 저지대 침수 피해에 유의하기 바란다. 오늘(30일) 남부지방은 중국 상해 부근에 위치한 고기압의 가장자리에 들겠고, 내일(10월 1일)은 전국이 서해남부해상에 위치한 고기압 가장자리에 들겠다. 모레(2일) 남부지방은 남해상에 위치한 고기압의 영향을 받겠다. 오늘(30일) 중부지방과 전라도는 서해상에 위치한 기압골의 영향을 받겠고, 모레(2일) 중부지방은 북쪽을 지나는 기압골의 영향을 받겠다.

종합 | 정진욱 기자 | 2020-09-30 10:23

-- 혈액에서 종양 세포 클러스터가 검출된 정상인, 1년 이내에 암 발생 위험 230배 높아 인도 뭄바이 및 런던, 2020년 9월 30일 /PRNewswire/ -- 미국암학회(American Association of Cancer Research, AACR)가 발간하는 명망 높은 학술지인 'Cancer Prevention Research'에 게재된 한 기념비적인 연구에 따르면, 간단한 혈액 채취로 암 발생 위험이 더 높은 건강한 사람을 찾아내는 것이 가능하다고 한다. 이 연구는 암 병력은 없지만, 검출이 가능한 혈중 순환 종양 세포 클러스터(clusters of Circulating Tumor Cells, 'C-ETACs')가 있는 일반적인 무증상 중년 남녀의 경우, 혈액 표본에서 그와 같은 클러스터가 없는 사람보다 1년 이내에 암이 발생할 위험이 230배나 더 높다고 보고했다. Datar Cancer Genetics의 주도로 진행된 이 다기관 국제 협력 연구 [ https://doi.org/10.1158/1940-6207.CAPR-20-0322 ]에서, 연구원들은 C-ETAC를 검출하고자 10,000명이 넘는 무증상 실험 참가자를 검사하고, 1년 동안 이들을 추적 관리했다. 동시에 다양한 악성 종양('고형 장기 암')을 보유한 4,000명 이상의 암 환자에서 채취한 혈액도 조사했다. 연구 결과, C-ETAC는 암 환자에서는 거의 예외 없이 발견됐지만(> 90%), 암 진단이나 증상이 없는 일반 개인에서는 매우 드문 것(

종합 | PR Newswire | 2020-09-30 07:00

산타클라라, 캘리포니아주, 2020년 9월 29일 /PRNewswire/ -- 피카로(Picarro Inc)다양한 공기 모니터링 응용 분야를위한 미량 가스 분석기의 선도적 인 공급 업체 는 대한민국 화성시에 고객 서비스지원 사무소를 개소함으로써 아시아에서 그 입지를 넓혀가고 있다. 영업 인력과 수리 서비스 및 교체 부품이 로컬에서 제공되므로 회사는 현지에서 날로 두터워지는 고객층을 더 원활히 지원할 수 있을 것으로 본고 있다. "매우 민감하고 정확한 분석기로 이루어진 당사의 포트폴리오는 반도체 및 장비 제조업체가 더 빨리 반도체 팹에서 공기 중 분자 오염을 식별하고 줄일 수 있게 함으로써, 결과적으로 수율 향상에 기여할 수 있습니다."라고 존 박(John Park), 피카로(Picarro) 한국 총괄 책임자가 말했다. 한국에 소재하고 있는 반도체 제조사, 반도체 장비 제조사 그리고 다른 산업에 있어서는 연구용 측정기 목적으로써 채용하는 수가 증가되고 있어 당사가 현지에서 입지를 공고히 다지는 것이 중요합니다"라고 말을 이었다. 존 박(John Park)은 한국 사무소를 이끌 예정이다. 대한민국의 반도체 장비 및 소재 사업에서 20년 이상 경력을 쌓았다. 피카로(Picarro)에 입사하기 전에 그는 토소 SMD 코리아(Tosoh SMD Korea) 및 유니테스트(UnitTest, Inc.)에서 성공적으로 영업팀을 이끌었으며 현지의 여러 유수 전자 및 반도체 기업과 관계를 구축해 왔다. 그는 한국의 울산대학교에서 금속공학 학사 학위를 취득했다. Picarro 소개 피카로(Picarro)는 업계 최고의 실시간 AMC 모니터링 솔루션을 공급합니다. 공동 광자 감쇠 분광법(Cavity Ring-Down Spectroscopy, CRDS) 기술은 이온 이동도 분석법(Ion-Mobility Spectrometry, IMS) 및 이온 크로마토그래피와 같이 현존하는 다른 AMC 측정 기법보다 더욱 중요한 장점들을 가지고 있습니다. 피카로(Picarro)의 SI Series 분석기는 시간이 아닌 초 단위로 클린룸에서 오염물질에 대한 고속의 반응을 가능하게 해줍니다. 실시간 연속 ppt(parts-per-trillion : 1조 분의 1) 수준의 분석으로 피카로(Picarro) 분석기는 클린룸, FOUP 및 팹(FAB) 장비에서 AMC 모니터링의 오염 이벤트에 대한 조기 경고를 제공합니다. 자세한 내용은 semi.picarro.com을 참조하십시오. 연락처:시이리 하게(Siiri Hage)마케팅 통신 책임자피카로(Picarro, Inc.)shage@picarro.com 로고 - https://mma.prnasia.com/media2/1091786/Picarro_Logo.jpg?p=medium600Related Links :http://www.picarro.com

종합 | PR Newswire | 2020-09-29 22:48

SANTA CLARA, California, Sept. 29, 2020 /PRNewswire/ --  Picarro Inc., a leading provider of trace gas analyzers for a variety of air monitoring applications, is expanding its presence in Asia by opening a customer service and support office in Hwaseong, South Korea. Having sales staff, repair services, and replacement parts available locally will allow the company to better support its growing customer base there. "Our portfolio of extremely sensitive and accurate analyzers enables semiconductor and equipment manufacturers to identify and mitigate airborne molecular contamination in the fab faster, resulting in better yield," said John Park, General Manager at Picarro. "With several key semiconductor fabs and equipment manufacturers located in South Korea, and increasing adoption of our scientific instruments in other industries, it's important that we have a robust presence there." John Park will head up the Korea office. Park has more than 20 years of experience in the semiconductor equipment and materials business in Korea. Prior to joining Picarro, he led successful sales teams at Tosoh SMD Korea and UnitTest Inc. and has established relationships with leading electronics and semiconductor companies there. He earned a B.A. in metallurgical engineering at Ulsan University in Korea. About Picarro Picarro provides industry leading solutions for real-time AMC monitoring. Their cavity ring-down spectroscopy (CRDS) technology offers significant advantages compared with incumbent AMC measurement techniques, such as ion-mobility spectrometry (IMS) and ion chromatography. Picarro's SI Series analyzers enable fast response to contaminants in the cleanroom in seconds, not hours. With real-time continuous parts-per-trillion (ppt) level analysis, Picarro analyzers provide early warning of contamination events for AMC monitoring in cleanrooms, FOUP, and fab equipment. For additional information, please visit semi.picarro.com. Contact: Siiri Hage Director of Marketing Communications Picarro, Inc. shage@picarro.com Logo - https://mma.prnasia.com/media2/1091786/Picarro_Logo.jpg?p=medium600 Related Links :http://semi.picarro.com

종합 | PR Newswire | 2020-09-29 22:48

SEOUL, South Korea, Sept. 29, 2020 /PRNewswire/ -- The new product, an AI-based threat information extraction and APT attack response system, prevents malicious code and phishing through email and provides real-time threat information. SecuLetter, a member company of the Born2Global Centre, has launched an integrated security product, named the "KT Intelligent Threat Email Analysis Solution," in cooperation with KT Corporation (KRX: 030200; NYSE: KT). KT, Korea's largest telecommunications service provider, is leading the new era of innovations in one of the world's most connected countries with 5G, Big Data, Cloud, IoT, Blockchain and other transformative technologies. KT launched the world's first nationwide commercial 5G network in April 2019, after showcasing the first trial 5G services at the PyeongChang Winter Olympic Games in February 2018. To help cope with COVID-19, KT is staging a social campaign, dubbed "Ma-Eum:TACT (Heart to Heart)," providing technology supports for people and businesses in need. KT will deliver most essential and innovative services and solutions to its customers around the world as the first frontier in the next technology revolution and number one Global ICT Company. From April of this year, SecuLetter has been conducting interlocking and verification tests of KT's A.I. (Artificial Intelligence) and SecuLetter products, and after signing a strategic business alliance agreement in August, SecuLetter and KT have jointly launched an integrated security product. The security solution allows customers to detect and block various threats—such as malicious code infections, phishing, ransomware, and APTs (Advanced Persistent Threats) that attempt to attack the user's computer through email—and quickly and comprehensively protects the user's information and assets. The application of KT's A.I. analysis technology, which is based on the learning and analysis of 200 million emails per year, enables the system to detect new threats such as phishing, URLs, and malicious code executable files as well as to provide A.I.-based threat information. In terms of malicious code analysis, the system has also been applied with SecuLetter's proprietary reverse engineering platform technology, which supports multi-level diagnosis and analysis of malicious codes to detect, diagnose, analyze, and block suspicious documents and other threats. The technology is also equipped with various features that help protect against any of the APT's security blind spots. Head of the KT Corporate Service Division, Mr. Lee, Jin-woo said, "KT pursues innovation every day to provide customer-oriented services, and the recently launched solution also reflects this vision. In other words, it combines KT's A.I. and security threat intelligence with the most advanced and comprehensive malware detection and blocking technologies needed by customers. This solution will be of great help to customers who want to increase their corporate information protection and business continuity." SecuLetter CEO Lim, Chasung said, "We are happy to release commercially available products in cooperation with KT. This product provides services by level (Basic, Standard, and Enterprise) according to the customer's network environment and budget for system introduction. Currently, we are receiving good responses from Korean financial institutions and a number of local government agencies, so we expect good results within the year." SecuLetter's other products, "SecuLetter Email Security" and "SecuLetter File Security" are actively being used by major national institutions, financial institutions, and companies, including KEPCO E&C, Korea Post Information Center, KISA (Korea Internet & Security Agency), BNK Busan Bank, KAMCO (Korea Asset Management Corporation), KSD (Korea Securities Depository), Ulsan Port Authority, and UBASE. For more detailed information on SecuLetter, visit https://www.seculetter.com/content/en/. Media contact SecuLetter: contact@seculetter.com Born2Global Centre: jlee@born2global.com Photo: https://drive.google.com/drive/folders/1DBKpW2_bWHuCUTjY0EdWVKGw8d71f8vk?usp=sharing

종합 | PR Newswire | 2020-09-29 21:30

- Panchshil Realty의 CSR 단체인 Panchshil 재단, Chahal에게 축하 인사 전해 푸네, 인도 2020년 9월 29일  /PRNewswire/ -- 뭄바이 시청(Municipal Corporation of Greater Mumbai) 시 위원인 Iqbal Singh Chahal, I.A.S.가 인도의 금융 수도 뭄바이에서 신종 코로나바이러스 감염증을 억제하는 데 기여하고, 아시아 최대의 슬럼가인 다라비를 포함해 뭄바이의 혼잡 지역에서 질병의 '확산세를 둔화"시킨 공로를 인정받아, 인도 공무원으로는 처음으로 세계적으로 인정받은 상을 받게 됐다. jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE="   jwplayer('myplayer1').setup({file: 'https://mma.prnasia.com/media2/1282612/BMC_commissioner_Iqbal_Singh_Chahal.mp4?p=medium600', image: 'http://www.prnasia.com/video_capture/null_KO38269_1.jpg', autostart:'false', aspectratio: '16:9', stretching : 'fill', width: '600', height: '338'}); 1989년 동기 마하라슈트라 간부단 장교로서 30년 동안 인도 정부 및 마하라슈트라 정부와 일해온 풍부하고 다양한 경험을 보유한 그는 인도 관료 부문에서 인도-미국 상공회의소(Indo American Chamber of Commerce, IACC)가 수여하는 'Covid Crusader Award-2020'을 수상했다. 1968년에 설립된 IACC는 인도-미국 경제 참여에서 시너지 효과를 내는 최고의 양국 간 상공회의소다. Covid Crusader Award는 IACC와 뭄바이 주재 미국영사관이 공동으로 제정한 것이다. 가상 시상식에서 마하라슈트라 주지사 Bhagat Singh Koshyari가 이 상을 수여했다. Chahal은 "이 상을 받게 된 것을 영광이자 특권이라 여기며, 그와 동시에 매우 겸손한 마음이 든다"라며 "인도-미국 상공회의소에 감사드리며, 더불어 심사위원단에도 감사드린다"고 소감을 밝혔다. 이어 그는 "코로나19와의 전쟁에서 네 가지 핵심 요소는 검사, 구급차, 환자 관리 및 병원 관리"라면서 "우리 지역에서는 이들 업무가 자동으로 진행되고 있다. 다른 후보도 마찬가지로 유능하고, 상을 받을 자격이 충분할 것이다. 그들도 그 자체로 수상자라고 생각한다"라고 덧붙였다. Panchshil Realty 회장 Atul Chordia는 "마하라슈트라의 시 위원이 국제적인 상을 받은 것에 큰 자부심이 느껴진다"라며 "우리가 알던 일상생활을 와해시킨 신종 코로나바이러스와의 싸움에서 헌신적이고, 집중적이며, 끈질긴 모습을 보여주며, 이 명예로운 국제 상을 받은 Chahal에 감사드린다. 앞으로 계속될 코로나19 팬더믹과의 전쟁에서 그에게 최고의 행운이 따르길 바란다"고 말했다. Panchshil 재단은 코로나19의 구호, 교육, 건강, 예술 및 문화, 스포츠, 기반시설, 소셜 이니셔티브 영역에서 프로그램을 맡고 있다. Panchshil Realty의 주요 사업 부문은 상업 사무실 공간, 병원 및 주거 부동산 영역이다. Panchshil Realty의 사무실 포트폴리오 중 상당 부분이 Blackstone Group LP가 지원하고 관리하는 Blackstone Real Estate Private Equity Fund를 기반으로 한다. Panchshil에 관한 추가 정보는 웹사이트 www.panchshil.com을 참조한다. 영상: https://mma.prnasia.com/media2/1282612/BMC_commissioner_Iqbal_Singh_Chahal.mp4?p=medium600 로고: https://mma.prnasia.com/media2/1169295/Panchshil_Foundation_Logo.jpg?p=medium600   

종합 | PR Newswire | 2020-09-29 17:34

SEOUL, South Korea, Sept. 29, 2020 /PRNewswire/ -- Premium Korean beauty skincare brand from Korea Ginseng Corp (KGC), DONGINBI, is launching on Amazon today. The launch will celebrate with a limited time discount up to 40% off the signature products.  Korea Ginseng Corp (KGC) Unveils DONGINBI, Functioning Premium Red Ginseng Skincare Solution, on Amazon DONGINBI was created in 1899 based on Cheong Kwan Jang's philosophy of creating Korean red ginseng for external use. Various Red Ginseng ingredients offer a number of powerful skin-enhancing benefits, such as increased firmness, elasticity and brightness. It's also packed with antioxidants and anti-inflammatory properties, which help to soothe the skin, improve skin cell regeneration, and fight free-radical damage, which make DONGINBI's formulations perfect for all skin types, even the most sensitive. Utilizing red ginseng from Cheong Kwan Jang, DONGINBI has created the ultimate condensed formulations using a combination of three core types of advanced red ginseng technology in the form of a red ginseng water, oil, and extract. The high concentration of six-year red ginseng root with active ingredients is richly infused in each of DONGINBI's five product lines for a complete skincare routine - 1899, Red Ginseng Power Repair, Red Ginseng Moisture and Balancing, Red Ginseng Daily Defense, Red Ginseng Mi Mask Stick.The brand has plans for additional product drops following the foundational launch.  As a brand committed to becoming a world-class global corporation, DONGINBI is KGC's next step to develop premium, luxurious skin care products. All products retail for $27.99 - $169.99 and will be available for purchase on Amazon.com starting September 28, 2020. 1899 Signature Oil: One drop per root antioxidant synergy oil containing high purity red ginseng oil created with the essence of 1899 technology. 1899 Signature Oil is now available on Amazon. 1899 Single Essence: First Essence that carries 100% red ginseng extract which demonstrate the excellent antioxidative action from the single ingredient delivers the clear, sleek, and shiny skin. 1899 Single Essence is now available on Amazon. Red Ginseng Mi Mask Stick Vital: Vital mask infused with Natural Clear Skin Formula protects skin exhausted by external environment and restores healthy. Red Ginseng Mi Mask Stick Vital is now available on Amazon. Red Ginseng Moisture & Balancing Emulsion: Deep moisturizing emulsion with moisture energy from condensed red ginseng water that provides a balanced care for healthy and luminous skin. Red Ginseng Moisture & Balancing Emulsion is now available on Amazon. Red Ginseng Daily Defense Essence: Daily base essence with Natural Clear Skin Formula that protects skin weakened by the external environment and boosts the skin's natural energy to leave a firm and healthy finish. Red Ginseng Daily Defense Essence is now available on Amazon. Red Ginseng Power Repair Intense Eye Cream: Premium eye cream that creates smooth, lucid eyes by improving firmness around the delicate eye zone. Red Ginseng Power Repair Intense Eye Cream is now available on Amazon. For more information please visit: https://www.donginbi.com/ and follow us on Facebook.   Related Links :https://www.donginbi.com/

종합 | PR Newswire | 2020-09-29 08:00

(서울, 한국 2020년 9월 28일 PRNewswire=연합뉴스) 추석 연휴 기간에 장기간 많은 교통이동이 예상되는 만큼 차량 관리와 더불어 차량보험도 똑똑하게 준비해야 사고 처리 시 제대로 도움을 받을 수 있다. 사실 자동차보험 시장은 시시각각 변화하고 있기 때문에 운전자들 입장에서는 자동차보험 시장의 동향을 수시로 살펴볼 필요가 있는데, 특히 오프라인 자차보험에 비해 저렴한 온라인 자동차보험종류를 알아보고 자동차보험가격비교를 해본다면 자동차보험료를 획기적으로 절약할 수 있다. 보험닷컴에서 운영하는 자동차다이렉트보험비교견적사이트인 '자동차보험다모아몰'의 경우 해당 사이트에서 제공되고 있는 자동차보험료계산기 서비스를 통해 견적 산출 시 자동차보험료를 15~20% 정도 절감할 수 있고, 보험 특약을 활용한 자신에게 알맞은 맞춤 자동차보험을 찾아볼 수 있어 가성비적으로 유용하다는 평가다. 자동차다이렉트보험비교견적사이트인 ‘자동차보험다모아몰’ 먼저 다이렉트 자동차보험 비교견적사이트에서 특약별 보장내용과 금액을 체크해봐야 한다. 차량 보유자는 반드시 자동차 책임보험에 가입해야 하는데, 대부분의 운전자들은 자동차보험 보장 범위가 좁기 때문에 자동차종합보험 형태로 준비하는 편이다. 혹시 모를 차량 사고 처리를 원활하게 하기 위해 준비하는 것인 만큼 기본 자동차보험 책임특약(자동차보험 대물 배상 및 대인배상, 자동차상해, 무보험차상해, 자기차량손해, 자기신체사고, 긴급출동 서비스 등)별 보장 내용을 정확하게 확인하고 사고 처리 시 제대로 지원받을 수 있도록 자동차보험을 꼼꼼히 준비하는 것이 중요하다. 다음으로 자동차보험다이렉트 비교견적을 최적화해주는 할인 특약을 잘 활용하면 자동차보험료를 보다 획기적으로 절약할 수 있다. 주요 자동차보험료 할인특약으로는 운전자한정 특약, 주행거리 마일리지, 블랙박스, 자녀할인, 안전운전할인, 요일제 할인, 대중교통이용할인, 첨단안전장치, 무사고 할인 특약 등이 있으며, 본인의 조건에 맞게 활용하면 최대 60%까지도 자동차보험료 절감이 가능하니 본인의 조건에 맞는 운용이 필수적이다. 이 밖에도 신규자동차보험 가입이나 자동차보험 갱신을 앞두고 있어 자동차보험종류를 알아보고 있다면 할인 특약을 제대로 활용하면 자동차보험료 지출을 줄일 수 있다. 앞서 언급한 할인 특약 외에도 친환경 에코 부품 사용 할인, 차선이탈 경고장치 특약, 기초생활 수급자 및 서민 할인, 티맵안전운전할인, 운전경력인증 등과 같이 자동차보험료 할인이나 환급을 받을 수 있는 특약 등 다양하게 있기 때문에 자신에게 해당되는 자동차보험 특약이 있는지를 인터넷자동차보험 비교견적사이트에서 먼저 체크해보고 알맞게 선택 가입하도록 해야 한다. 현재 캐롯 자동차보험, 현대해상 다이렉트 자동차보험, 메리츠화재 다이렉트 자동차보험, KB 다이렉트 자동차보험, 흥국화재 다이렉트 자동차보험, DB 다이렉트 자동차보험(동부화재 다이렉트 자동차보험), 한화 다이렉트 자동차보험, 더케이 자동차보험, 교보악사 다이렉트 자동차보험 등이 있으며, 내가 가입한 자동차보험조회(자동차보험이력조회)부터 다이렉트자동차보험순위까지 확인해 볼 수 있어 유용하다. 개인별 자동차보험 추천상품뿐만 아니라 자동차보험 할증기준까지 합리적으로 준비할 수 있어 가입 시 소비자 측면에서 유리한 만큼 적극적으로 활용해본다면 적잖은 도움이 될 수 있을 것이다. 링크: http://carinsu-plus.com    

종합 | PR Newswire | 2020-09-29 00:00

Daewoong Pharmaceutical's enavogliflozin to demonstrate remarkable blood glucose lowering effect and favorable safety in type 2 diabetic patients through phase 2 clinical trial Presented and demonstrated the result of phase 2 clinical trial in Korean patients with type 2 diabetes at the international 2020 ICDM Aims to accelerate R&D for global market expansion through establishment of comprehensive partnerships abroad SEOUL, South Korea, Sept. 28, 2020 /PRNewswire/ -- Daewoong Pharmaceutical (Daewoong) (CEO Sengho Jeon) announced the result of its phase 2 clinical trial on enavogliflozin, SGLT2 inhibitor for diabetes currently in the process of development, for the first time at the 2020 International Congress of Diabetes and Metabolism (ICDM) held on Sep. 18-19. The 2020 ICDM, an international conference sponsored by the Korean Diabetes Association (KDA), was held for the tenth time this year. It was organized as an online event to prevent the spread of COVID-19. When enavogliflozin was administered for 12 weeks in type-2 diabetic patients with inadequate glycemic control by diet and exercise, the patients showed statistically significant decreases in their glycated hemoglobin (HbA1c) levels in comparison to the placebo starting from week 4. In week 12, the patients' glycated hemoglobin levels decreased approximately 0.9%p in comparison to the placebo. This is a statistically significant result and indicates an additional decrease in the glycated hemoglobin by approximately 0.2–0.3%p compared to SGLT2 inhibitors of other companies for which trials were conducted in subjects in Western countries. This result, as such, raises expectations for further studies. Changes in HbA1c from the baseline through 12-week administration (left) Percentage of Patients Displaying HbA1c

종합 | PR Newswire | 2020-09-28 21:00

DAEJEON, South Korea, Sept. 28, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a leading exosome-based therapeutics company, announced today that the Company has completed a Series B financing round of $20.6 million in South Korea. The initial investors from the Series A round, HB Investment, Timefolio Asset Management, and Daedeok Venture Partners joined this round with follow-on investment. The new institutional investors, including Asset One, Devsisters Ventures, Meritz Securities, Kiwoom Securities, Daishin Securities, Hanyang Securities/Yeolim Partners, and Genie Asset Management joined this round along with a small number of private investors. ILIAS has raised a total of $40.2 million of capital since its foundation in November 2015. This financing will support the continued development of ILIAS's proprietary EXPLOR® (Exosome engineering for Protein Loading via Optically Reversible protein–protein interaction) platform technology and the advancement of exosome-based therapeutics pipeline. ILIAS recently published promising preclinical data on its lead therapeutic candidate, ILB-202, in Science Advances, and secured a key exosome engineering patent from the United States Patent and Trademark Office (USPTO) in July. While the Company plans to submit the IND application to U.S. FDA and initiate the first-in-human clinical trial by the 2nd half of 2021 targeting an undisclosed acute inflammatory disease, it is also in active discussion with multiple pharmaceutical companies for potential research collaborations. EXPLOR® technology is a novel protein-loading method that enables free form loading of large therapeutic cargo proteins into the lumen of exosomes—nanosized, cell-derived extracellular vesicles—by genetically engineering the producing cell lines. While exosomes have been actively studied as novel therapeutic vehicles for intracellular drug delivery, the controllable loading of therapeutic cargo proteins as a free form in the exosomal lumen has remained a technical hurdle. ILIAS's technology provides a unique solution to overcome this challenge and increase the efficiency of therapeutic protein delivery into the intracellular component of target cells. "The support from our new and existing investors is a reflection of their confidence in the immense potential of ILIAS's exosome-based platform technology and the expertise of scientists and management teams at ILIAS," said Dr. Chulhee Choi, CEO of ILIAS Biologics. "We will continue to work toward fulfilling our mission of transforming scientific imaginations into reality to advance human health." ILIAS has been recently finalizing the underwriter contract with securities companies, planning for an IPO to KOSDAQ (Korea Securities Dealers and Automated Quotation) in Q1 2022. About ILIAS Biologics Inc. ILIAS Biologics Inc. (previously Cellex Life Sciences, Inc.) was established in 2015 in South Korea to develop exosome-based therapeutics. ILIAS is currently developing various pipelines including inflammatory diseases and oncology. To learn more about ILIAS Biologics Inc, visit the website at www.iliasbio.com.

종합 | PR Newswire | 2020-09-28 20:00

Partnership to offer improved operational efficiency and increased business value to clients BENGALURU, India, Sept. 28, 2020 /PRNewswire/ -- EdgeVerve Systems, a wholly-owned subsidiary of Infosys, recently signed a partnership with Minit, a leader in process mining, to help clients accelerate process excellence. The two market leaders will jointly create a solution that will empower enterprises with superior insights for business transformation, leading to better operational efficiency and enhanced business results. Often, enterprises struggle to identify root causes of unexpected outcomes like resource underutilization, process inefficiency, failed automation deployments resulting from biased interpretation of processes. This end-to-end solution will not only address these concerns but also assure automation success to enterprises. Whether it is about improving process efficiency through quantifiable assessment of business user behavior, or simulating several new processes spanning global business units, by combining the capabilities of AssistEdge Discover's process discovery and Minit's process mining, this solution can assist organizations transform into a hyper-productive enterprise. Rasto Hlavac, Founder and CEO of Minit said, "Process Mining solutions help businesses thoroughly and objectively analyze and improve their processes. Through insights, organizations can boost their continuous improvement initiatives and increase operational efficiency. Extending the solution to Process Discovery enables us to achieve greater granularity and visibility up to the level of specific tasks performed by users. We are excited to partner with EdgeVerve to jointly bring this comprehensive picture and provide the springboard for our clients to achieve exponential transformation benefits." Atul Soneja, SVP and Global Head of Edge and Infosys Nia, said, "A transformative solution, AssistEdge Discover leverages empirical data to capture process gaps and scope of optimization, laying the foundation for operational performance improvement. Combining the power of Process Discovery with Process Mining reveals end-to-end process insights. These insights help organizations unearth new opportunities and act as a catalyst in driving sustained growth and innovation. We are excited to partner with Minit as it will help us deliver increased business value to our clients, leading to a more resilient future." About Minit As one of the leading market providers of Process Mining solution, Minit helps businesses transform the way they analyze, monitor, and optimize their processes to uncover opportunities for continuous process improvement and higher operational efficiency. Minit believes that every organization can achieve digital transformation and operational excellence. Through its solution, the company inspires stakeholders to take action and explore the benefits of the Process Mining technology for their organizations. Minit provides its Fortune 500 customers as well as other businesses with complex processes with a unique experience, highly added value, and competitive insights to help them run efficient organizations. Visit www.minit.io to learn how to achieve seamless processes in your company. About AssistEdge Discover AssistEdge Discover unlocks the hidden business value trapped in your processes. It acts as a powerful foundation for enterprises seeking cutting-edge technology, to drive intelligent automation and process excellence. From non-intrusively capturing human-machine interactions to leveraging AI to creating actionable process insights, AssistEdge Discover sets you on the right path to embrace continuous improvement with relentless focus on creating a hyper productive enterprise. https://www.edgeverve.com/assistedge/assistedge-discover/ About EdgeVerve Systems Ltd EdgeVerve Systems Limited, a wholly owned subsidiary of Infosys, is a global leader in AI and Automation, assisting clients thrive in their digital transformation journey. Our mission is to create a world where our technology augments human intelligence and creates possibilities for enterprises to thrive. Our comprehensive product portfolio across AI (Infosys Nia), Automation (AssistEdge) and AI enabled Business Applications (TradeEdge, FinXEdge, ProcureEdge) helps businesses develop deeper connections with stakeholders, power continuous innovation and accelerate growth in the digital world. Today EdgeVerve's products are used by global corporations across financial services, insurance, retail, consumer & packaged goods, life sciences, manufacturing telecom and utilities. Visit us to know how enterprises across the world are thriving with the help of our technology.   About Infosys Infosys is a global leader in next-generation digital services and consulting. We enable clients in 46 countries to navigate their digital transformation. With nearly four decades of experience in managing the systems and workings of global enterprises, we expertly steer our clients through their digital journey. We do it by enabling the enterprise with an AI-powered core that helps prioritize the execution of change. We also empower the business with agile digital at scale to deliver unprecedented levels of performance and customer delight. Our always-on learning agenda drives their continuous improvement through building and transferring digital skills, expertise, and ideas from our innovation ecosystem. Visit www.infosys.com to see how Infosys (NYSE: INFY) can help your enterprise navigate your next. Safe Harbor Certain statements in this release concerning our future growth prospects, financial expectations and plans for navigating the COVID-19 impact on our employees, clients and stakeholders are forward-looking statements intended to qualify for the 'safe harbor' under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding COVID-19 and the effects of government and other measures seeking to contain its spread, risks related to an economic downturn or recession in India, the United States and other countries around the world, changes in political, business, and economic conditions, fluctuations in earnings, fluctuations in foreign exchange rates, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which Infosys has made strategic investments, withdrawal or expiration of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property and general economic conditions affecting our industry and the outcome of pending litigation and government investigation. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2020. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company's filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.  

종합 | PR Newswire | 2020-09-28 19:55

- Panchshil Foundation, the CSR Arm of Panchshil Realty, Congratulates Chahal PUNE, India, Sept. 28, 2020 /PRNewswire/ -- Iqbal Singh Chahal, I.A.S., Municipal Commissioner of the Municipal Corporation of Greater Mumbai, has become the first Indian bureaucrat to be recognised and receive global acknowledgment for his contribution in controlling the novel coronavirus infection in India's financial capital and for working to 'flatten the curve' in congested areas of the city, including Asia's biggest slum Dharavi. jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE="   jwplayer('myplayer1').setup({file: 'https://mma.prnasia.com/media2/1282612/BMC_commissioner_Iqbal_Singh_Chahal.mp4?p=medium600', image: 'http://www.prnasia.com/video_capture/3138269_AE38269_1.jpg', autostart:'false', aspectratio: '16:9', stretching : 'fill', width: '600', height: '338'}); The 1989-batch Maharashtra cadre officer - with 3 decades of rich and diverse experience with the Government of India and the Government of Maharashtra - has been conferred the top 'Covid Crusader Award-2020' by the Indo American Chamber of Commerce(IACC) in the Indian Bureaucrats Category. The IACC, established in 1968, is the apex bi-lateral Chamber synergizing India-US Economic Engagement. The award was instituted by the IACC and the US Consulate in Mumbai. The award was conferred by the Hon. Maharashtra Governor Bhagat Singh Koshyari at a virtual ceremony. "It is my honour and privilege to receive this award and I accept this recognition with a sense of great humility. I am grateful to the Indo American Chamber of Commerce. I am also thankful to the jury. The 4 pillars of our Covid-19 fight namely testing, ambulances, patient management, hospital management, have all been put on auto pilot. I am sure the other nominees are equally competent and deserving and they are winners in their own right," Chahal said in his acceptance address. "It is a matter of great pride that a civic chief from Maharashtra has received global recognition and I congratulate Chahal for receiving this prestigious global award for his dedicated, focused  and relentless crusade against the novel coronavirus which has disrupted normal life as we know it. I wish him the very best in his on-going efforts to tackle this pandemic," said Atul Chordia, Chairman, Panchshil Realty. The Panchshil Foundation undertakes initiatives in the areas of Covid-19 relief, education, health, art & culture, sports, infrastructure and social initiatives. Panchshil Realty's main business verticals are commercial office space, hospitality and residential real estate. A significant chunk of Panchshil Realty's office portfolio is anchored by Blackstone Real Estate Private Equity Fund, sponsored and managed by Blackstone Group LP. For more information about Panchshil, please visit www.panchshil.com Video: https://mma.prnasia.com/media2/1282612/BMC_commissioner_Iqbal_Singh_Chahal.mp4?p=medium600 Logo: https://mma.prnasia.com/media2/1169295/Panchshil_Foundation_Logo.jpg?p=medium600 

종합 | PR Newswire | 2020-09-28 19:08